Form 4 · Filed Jun 16, 2026, 12:58 AM UTC
CVKD/Cadrenal Therapeutics, Inc.
Pham Quang X — Chairman and CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | S | sell | 3,666 | $4 | $13,124 | 132,715 |
| Jun 12, 2026 | S | sell | 12,996 | $4 | $51,204 | 136,381 |
| Jun 11, 2026 | S | sell | 1,462 | $4 | $6,023 | 149,377 |
Source: SEC EDGAR raw filing ↗ · Accession 0001213900-26-068981